Target intelligence / Profile preview

Mucus gel

Molecular classification
Other (biological hydrogel), Glycoprotein-rich network, Extracellular barrier structure
01

Overview

The "mucus gel" is not a single molecule or receptor but rather a hydrated biological hydrogel composed primarily of large glycoproteins called gel-forming mucins. These macromolecules form an intricate network that lines and protects epithelial surfaces throughout the body—including respiratory, gastrointestinal, urogenital tracts, eyes, and more. The mucus gel acts as a dynamic physical barrier against dehydration, mechanical stress, pathogen invasion, toxins, and chemical insults while also facilitating lubrication for tissue movement. Its structure is highly complex due to extensive glycosylation patterns on mucin proteins—mainly MUC5AC from goblet cells and MUC5B from submucosal glands—which confer unique viscoelastic properties essential for trapping particles yet allowing ciliary transport. The composition includes 93–97% water with 3–7% solids made up mostly by these glycoproteins along with lipids, salts, enzymes like lysozyme/proteases/DNases/antimicrobial peptides/immunoglobulins/cellular debris. The balance between solid-like elasticity (from cross-linked networks) and fluid-like flow enables both robust protection under stress—such as coughing/peristalsis—and efficient clearance mechanisms. Alterations in the quantity/composition/rheology ("stickiness") of this layer are implicated in various diseases including infections where it serves as a first line defense; chronic inflammatory conditions where excessive production impairs function; genetic disorders like cystic fibrosis where abnormal hydration leads to impaired clearance; among others. Because it is not a discrete molecular target but rather an emergent property arising from many molecules' interactions within extracellular space—primarily polymerized secreted mucins—the "mucus gel" itself is not considered a canonical therapeutic target such as an enzyme/receptor/transporter would be.[1][2][3][4][5][6] In summary: > The term “mucus gel” refers collectively to the hydrated extracellular matrix formed by secreted polymeric mucin glycoproteins that provide critical protective functions at all wet-surfaced epithelia—not an individual molecule nor conventional drug target.[1][2]

Other names
Mucus layermucus hydrogelmucus blanketgel-forming mucin network
02

Mechanism of action

Drugs interacting with mucus gels typically act by modifying its viscosity or promoting its clearance. For example, - Breaking disulfide bonds in mucins to reduce viscosity (N-acetylcysteine)[4] - Enzymatic degradation of DNA/proteins within the gel to thin secretions[4]

03

Biological functions

Barrier protection of mucosal surfacesLubrication of epithelial tissuesTrapping and clearance of pathogens and debrisRegulation of nutrient passage and absorptionSupport for microbiota colonizationModulation of cell adhesion and signaling[5][6][8]
04

Disease associations

Infection (as a barrier to pathogens)Inflammation (altered in diseases like cystic fibrosis or chronic bronchitis)Gastrointestinal disorders (e.g., ulcerative colitis, Crohn’s disease)Respiratory diseases (e.g., asthma, COPD)[5][8]
05

Safety considerations

Therapeutic challenges include difficulty delivering drugs across the mucus barrier due to its viscoelasticity and selective permeability. Over-thinning can compromise protective functions leading to increased infection risk[4][6].
06

Interacting drugs

Mucolytics (e.g., N-acetylcysteine, dornase alfa)

1 more in the full profile.

07

Biomarkers

No specific biomarkers for "mucus gel" itself; however, levels or properties of major mucins such as MUC5AC and MUC5B may be measured in disease contexts[3].

Beyond the preview

Go deeper on Mucus gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucus gel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call